Hoffmann-Vold, A. M., Fretheim, H., Maurer, B., Durheim, M., Midtvedt, Ø., Becker, M. O., … Distler, O. (2020). THU0331 INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS: DECLINE IN FORCED VITAL CAPACITY DOES NOT PREDICT FURTHER PROGRESSION IN THE FOLLOWING PERIOD. In Annals of the Rheumatic Diseases (Vol. 79, pp. 396–396). Elsevier BV. https://doi.org/10.1136/annrheumdis-2020-eular.5755

Hoffmann-Vold, A. M., H. Fretheim, B. Maurer, M. Durheim, Ø. Midtvedt, M. O. Becker, R. Dobrota, Ø. Molberg, S. Jordan, and O. Distler. “THU0331 INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS: DECLINE IN FORCED VITAL CAPACITY DOES NOT PREDICT FURTHER PROGRESSION IN THE FOLLOWING PERIOD.” In Annals of the Rheumatic Diseases, 79:396–396. Elsevier BV, 2020. https://doi.org/10.1136/annrheumdis-2020-eular.5755.

Hoffmann-Vold AM, Fretheim H, Maurer B, Durheim M, Midtvedt Ø, Becker MO, et al. THU0331 INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS: DECLINE IN FORCED VITAL CAPACITY DOES NOT PREDICT FURTHER PROGRESSION IN THE FOLLOWING PERIOD. In: Annals of the Rheumatic Diseases. Elsevier BV; 2020. p. 396–396.

Hoffmann-Vold, A. M., et al. “THU0331 INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS: DECLINE IN FORCED VITAL CAPACITY DOES NOT PREDICT FURTHER PROGRESSION IN THE FOLLOWING PERIOD.” Annals of the Rheumatic Diseases, vol. 79, Elsevier BV, 2020, pp. 396–396. Crossref, doi:10.1136/annrheumdis-2020-eular.5755.

Hoffmann-Vold AM, Fretheim H, Maurer B, Durheim M, Midtvedt Ø, Becker MO, Dobrota R, Molberg Ø, Jordan S, Distler O. THU0331 INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS: DECLINE IN FORCED VITAL CAPACITY DOES NOT PREDICT FURTHER PROGRESSION IN THE FOLLOWING PERIOD. Annals of the Rheumatic Diseases. Elsevier BV; 2020. p. 396–396.